Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
Clinical trial NCT06439576 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06439576
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-05-09
- Primary completion
- 2026-11-15
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.